Artemisinin Antimalarial Drugs Market Outlook:
Artemisinin Antimalarial Drugs Market size was valued at USD 680.16 million in 2025 and is set to exceed USD 1.2 billion by 2035, registering over 5.8% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of artemisinin antimalarial drugs is evaluated at USD 715.66 million.
The increasing prevalence of malaria is primarily augmenting the market growth worldwide. Underdeveloped and developing countries are mainly witnessing issues related to diseases caused by mosquitoes. For instance, according to a report by the World Health Organization (WHO), there were around 249 million cases of malaria, globally, in 2022. Such statistics underscore the need for effective treatment options, fuelling the market growth.
Africa is the most prevalent region for malaria, accounting for 94.0% of all malaria cases in 2022. The governments in the region are implementing several initiatives to increase disease awareness and care, this is generating lucrative opportunities for artemisinin antimalarial drug manufacturers.
